SYNTHESIS OF FLUORO-CONTAINING SUBSTITUTED 1,3,5-TRIAZINES

DOI: 10.1007/BF00953302

Source and publish data:

Bulletin of the Academy of Sciences of the USSR Division of Chemical Science p. 836 - 840 (1989)

Update date:2022-08-05

Topics:

Authors:

Shmel'kova, T. K.

Ignatenko, A. V.

Krukovskii, S. P.

Ponomarenko, V. A.

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1007/BF00953302

Full text of DOI:10.1007/BF00953302

Products guided by the article

Product name:2,2,3,3,4,4,5,5,6,6,7,7,7-Tridecafluoro-N-(imino-phenyl-methyl)-heptanamidine

Cas No:123528-68-7

R&D Labs maybe for 123528-68-7

Jiangsu Fengshan Group Co., Ltd.

Contact:86-25-86558671

Address:1903,Central International Mansion 105-6 North Zhongshan Road, Nanjing, China
Jiangsu Willing Bio-Tech Co ltd

website:http://www.willingbio.com/

Contact:+86 18796908173

Address:No 18 Guoqiao Road
Anhui Gusheng Import&Export CO.,LTD

Contact:86-551-63662296

Address:Jinzhai Road NO.162 ,hefei, china
Linyi VIHO Chemical Co.,Ltd

Contact:86-15588110016

Address:LINYI CITY,SHANDONG PROVINCE,CHINA
Shenzhen Sunrising Industry Co., ltd.

Contact:+86 755 86571158 / 86571159 / 86571160

Address:2108 ZHENYE INT. BUSINESS CENTER,NO.3101-90 QIANHAI RD, NANSHAN,SHENZHEN, CHINA

Relevant to this article

Metal-catalyzed reactions between 2-azabicyclo[2.2.1]hept-5-en-3-ones and arylboronic acids

Doi:10.1002/ejoc.201000135
(2010)
Synthesis and biological activity of N-aroyl-tetrahydro-γ-carbolines

Doi:10.1016/j.bmc.2010.04.034
(2010)
Evaluation of 3-(4′-(4″-fluorophenyl)-6′-phenylpyrimidin- 2′-yl)-2-phenylthiazolidin-4-one for in vivo modulation of biomarkers of chemoprevention in the 7,12-dimethylbenz[a]anthracene-induced hamster buccal pouch carcinogenesis

Doi:10.3109/14756366.2010.525507
(2011)
Novel synthesis of the isoflavone genistein

Doi:10.1055/s-0029-1219757
(2010)
Organocatalyst in Direct C(_sp²)-H Arylation of Unactivated Arenes: [1-(2-Hydroxyethyl)-piperazine]-Catalyzed Inter-/Intra-molecular C-H Bond Activation

Doi:10.1021/acs.joc.0c01019
(2020)
Defining the key pharmacophore elements of PF-04620110: Discovery of a potent, orally-active, neutral DGAT-1 inhibitor

Doi:10.1016/j.bmc.2013.06.045
(2013)

Article Doi